文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

p53调控的非凋亡性细胞死亡途径及其在癌症和其他疾病中的相关性。

p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases.

作者信息

Liu Yanqing, Stockwell Brent R, Jiang Xuejun, Gu Wei

机构信息

Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Department of Chemistry, Columbia University, New York, NY, USA.

出版信息

Nat Rev Mol Cell Biol. 2025 Apr 9. doi: 10.1038/s41580-025-00842-3.


DOI:10.1038/s41580-025-00842-3
PMID:40204927
Abstract

Programmed cell death is a mechanism that is crucial for numerous physiological and pathological processes. Whereas p53-mediated apoptosis is a major cell death pathway in cancer, accumulating evidence indicates that p53 also has crucial roles in controlling different non-apoptotic cell death (NACD) pathways, including ferroptosis, necroptosis, pyroptosis, autophagy-dependent cell death, entotic cell death, parthanatos and paraptosis, and may regulate PANoptosis, cuproptosis and disulfidptosis. Notably, the function of p53 in these NACDs substantially contributes to its biological effects, particularly in cancer development and other pathological processes. In this Review, we discuss recent advances in understanding the roles and underlying mechanisms of p53-mediated NACDs, focusing on ferroptosis, necroptosis and pyroptosis. We discuss the complex and distinct physiological settings in which NACDs are regulated by p53, and potential targeting of p53-regulated NACDs for the treatment of cancer and other human diseases. Finally, we highlight several important questions concerning p53-regulated NACDs that warrant further investigation.

摘要

程序性细胞死亡是一种对众多生理和病理过程至关重要的机制。虽然p53介导的细胞凋亡是癌症中的主要细胞死亡途径,但越来越多的证据表明,p53在控制不同的非凋亡性细胞死亡(NACD)途径中也起着关键作用,包括铁死亡、坏死性凋亡、焦亡、自噬依赖性细胞死亡、内吞性细胞死亡、PARP-1依赖性坏死、旁程序性死亡,并且可能调节PANoptosis、铜死亡和二硫死亡。值得注意的是,p53在这些NACD中的功能对其生物学效应有很大贡献,特别是在癌症发展和其他病理过程中。在本综述中,我们讨论了在理解p53介导的NACD的作用和潜在机制方面的最新进展,重点关注铁死亡、坏死性凋亡和焦亡。我们讨论了p53调节NACD的复杂且独特的生理环境,以及针对p53调节的NACD进行癌症和其他人类疾病治疗的潜在靶点。最后,我们强调了几个关于p53调节的NACD的重要问题,值得进一步研究。

相似文献

[1]
p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases.

Nat Rev Mol Cell Biol. 2025-4-9

[2]
Beyond apoptosis: evidence of other regulated cell death pathways in the ovary throughout development and life.

Hum Reprod Update. 2023-7-5

[3]
Mechanisms and therapeutic potential of multiple forms of programmed cell death in renal fibrosis.

Cell Signal. 2025-10

[4]
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.

J Cancer Res Clin Oncol. 2023-10

[5]
LncRNAs regulates cell death in osteosarcoma.

Sci Rep. 2025-7-2

[6]
Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer.

MedComm (2020). 2025-7-23

[7]
Cell death and cancer: Metabolic interconnections.

Cell Rep. 2025-6-24

[8]
Cuproptosis: a novel therapeutic mechanism in lung cancer.

Cancer Cell Int. 2025-6-24

[9]
Targeting p53 pathways: mechanisms, structures, and advances in therapy.

Signal Transduct Target Ther. 2023-3-1

[10]
The interplay of autophagy and non-apoptotic cell death pathways.

Int Rev Cell Mol Biol. 2020-1-13

引用本文的文献

[1]
Bioactive LDH nanoplatforms for cancer therapy: Advances in modulating programmed cell death.

Mater Today Bio. 2025-7-26

[2]
DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target.

Redox Biol. 2025-7-23

[3]
Emerging regulated cell death mechanisms in bone remodeling: decoding ferroptosis, cuproptosis, disulfidptosis, and PANoptosis as therapeutic targets for skeletal disorders.

Cell Death Discov. 2025-7-21

[4]
Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance.

Bioengineering (Basel). 2025-5-29

[5]
Distinct Types of Regulated Cell Death in Melanoma.

Cells. 2025-6-1

[6]
Antibacterial Activity of the p53 Tumor Suppressor Protein-How Strong Is the Evidence?

Int J Mol Sci. 2025-5-6

本文引用的文献

[1]
Understanding the complexity of p53 in a new era of tumor suppression.

Cancer Cell. 2024-6-10

[2]
Silent information regulator sirtuin 1 ameliorates acute liver failure the p53/glutathione peroxidase 4/gasdermin D axis.

World J Gastroenterol. 2024-3-21

[3]
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.

Cancer Cell. 2024-4-8

[4]
The positive feedback loop of the NAT10/Mybbp1a/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I/R injury.

Redox Biol. 2024-6

[5]
Knockdown of KIF23 alleviates the progression of asthma by inhibiting pyroptosis.

BMJ Open Respir Res. 2024-4-2

[6]
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia.

Eur J Haematol. 2024-7

[7]
International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis.

Autophagy. 2024-6

[8]
The cell biology of ferroptosis.

Nat Rev Mol Cell Biol. 2024-6

[9]
Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo.

Sci Adv. 2024-2-16

[10]
PHLDA2-mediated phosphatidic acid peroxidation triggers a distinct ferroptotic response during tumor suppression.

Cell Metab. 2024-4-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索